1. Home
  2. LPAA vs RPID Comparison

LPAA vs RPID Comparison

Compare LPAA & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Launch One Acquisition Corp. Class A Ordinary shares

LPAA

Launch One Acquisition Corp. Class A Ordinary shares

BUY

Current Price

$10.75

Market Cap

81.4M

Sector

N/A

ML Signal

BUY

Logo Rapid Micro Biosystems Inc.

RPID

Rapid Micro Biosystems Inc.

HOLD

Current Price

$1.69

Market Cap

84.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LPAA
RPID
Founded
2024
2006
Country
United States
United States
Employees
N/A
171
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
81.4M
84.8M
IPO Year
2024
2021

Fundamental Metrics

Financial Performance
Metric
LPAA
RPID
Price
$10.75
$1.69
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$8.00
AVG Volume (30 Days)
25.4K
209.9K
Earning Date
01-01-0001
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
2.78
EPS
N/A
N/A
Revenue
N/A
$33,587,000.00
Revenue This Year
N/A
$19.12
Revenue Next Year
N/A
$18.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
19.74
52 Week Low
$10.42
$1.58
52 Week High
$11.67
$4.94

Technical Indicators

Market Signals
Indicator
LPAA
RPID
Relative Strength Index (RSI) 45.24 34.39
Support Level $10.43 $1.66
Resistance Level $10.79 $2.18
Average True Range (ATR) 0.02 0.13
MACD -0.01 -0.05
Stochastic Oscillator 2.25 20.16

Price Performance

Historical Comparison
LPAA
RPID

About LPAA Launch One Acquisition Corp. Class A Ordinary shares

Launch One Acquisition Corp is a blank check company.

About RPID Rapid Micro Biosystems Inc.

Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.

Share on Social Networks: